The Future of ART Regimens for HIV Is in Long-Acting Agents

By News Health
5 hours Ago

(MedPage Today) — Recent developments in antiretroviral therapy (ART) include longer-acting therapies that don’t require a daily oral pill and two-drug regimens that could decrease toxicity associated with standard triple-drug regimens.
The…

Source link : https://www.medpagetoday.com/spotlight/hiv/116814

Author :

Publish date : 2025-08-04 17:18:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

Low-Cal Diet Plus Exercise May Help Patients With Hip OA

Nearly 17M U.S. Teens, Young Adults Eligible for GLP-1 Agonists

Novel T1D Therapy Opens the Door to Cell Transplants Sans Immunosuppressants

A White House Pandemic Office Is Being Sidelined. Here's Why That Matters

MS Therapy Management for Pregnancy May Raise Relapse Risk

Fewer Ocular Pressure Spikes With Drug Vials vs Popular Prefilled Syringes